Menu
Recruiting NCT05718128

Clinical Study of Endocardial Myocardial Biopsy

Phase IV Interventional Myocarditis Cardiomyopathies Heart Failure Cardiac Tumor

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Endocardiomyocardial biopsy.
Who it may be relevant to
Registry conditions: Myocarditis, Cardiomyopathies, Heart Failure, Cardiac Tumor. Basic parameters: 18 years — 80 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

In this study, patients with endocardial myocardial biopsy were selected to observe the safety of the operation, and pathological examination was performed. If necessary, special tests such as viral examination, mass spectrometry and molecular biology were performed to confirm the diagnosis, and follow-up was performed.

Interventions

  • Procedure Endocardiomyocardial biopsy
    Endocardiomyocardial biopsy

Primary outcome measures

  • Incidence of MACE-4 [Time frame: 10 year]

Eligibility criteria

Inclusion criteria

  • Patients with no gender restriction, age 18-80 years old, receiving endocardial myocardial biopsy in the Second Affiliated Hospital of Zhejiang University School of Medicine;
  • Patients with myocarditis, cardiomyopathy, heart failure and cardiac tumor of unknown clinical cause;
  • Have the ability to understand the test, can cooperate with investigators.

Exclusion criteria

  • Unable to understand or unwilling to fill in informed consent forms or follow visitors.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Diagnostic

Study locations

China · 1 center
  • 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China — Hangzhou

Identifiers

NCT: NCT05718128 · 2021-0131

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗